(Q41150439)

27 September 2017

Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis (English)

1 reference

27 September 2017

Pullar T

1

1 reference

27 September 2017

Hunter JA

series ordinal

2

1 reference

27 September 2017

Capell HA

series ordinal

3

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 December 1985

1 reference

Annals of the Rheumatic Diseases

27 September 2017

1 reference

27 September 2017

44

1 reference

27 September 2017

12

1 reference

27 September 2017

831-837

1 reference

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

An improved and simplified method of detecting the acetylator phenotype

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Acetylator phenotype in spontaneous SLE and rheumatoid arthritis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Salazopyrin in rheumatoid arthritis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Clinical Pharmacokinetics of Sulphasalazine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Simplified screening test for phenotyping of isoniazid inactivators

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Which component of sulphasalazine is active in rheumatoid arthritis?

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Simplified method for determining acetylator phenotype.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001793

Sulphasalazine in rheumatoid arthritis

19 August 2018

1 reference

12 December 2020

A biochemical assessment of sulphasalazine in rheumatoid arthritis

1 reference

12 December 2020

Is Plasma Level Monitoring of Sulfasalazine Indicated in the Treatment of Crohnʼs Disease or Ulcerative Colitis?

1 reference

12 December 2020

Acetylator phenotype and the effect of dapsone in rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.44.12.831

1 reference

27 September 2017

1 reference

27 September 2017

PubMed publication ID

2867746

1 reference